Stay updated on Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial page.

Latest updates to the Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial page
- Check3 days agoChange DetectedThe page now shows Revision: v3.5.5, indicating an updated build of the study record. This change is a backend revision tag rather than a modification to the study details.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating an update to the page's version of the study record.SummaryDifference0.0%

- Check46 days agoChange DetectedUpdates the displayed ClinicalTrials.gov page revision from **v3.5.2** to **v3.5.3**.SummaryDifference0.0%

- Check53 days agoChange DetectedAdded Ono Pharmaceutical Co., Ltd. and Revision: v3.5.2; removed Ono Pharmaceutical Co. Ltd and Revision: v3.5.0.SummaryDifference0.1%

- Check68 days agoChange DetectedLocation entry for Italy 35128 updated from Padua to Padova. Padova, Italy, 35128 is now listed as a site.SummaryDifference0.0%

- Check82 days agoChange DetectedUpdated the location from Napoli, Italy, 80131 to Naples, Italy, 80131. Updated the page revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial page.